Literature DB >> 19749401

Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta(42).

Emily House1, Matthew Mold, Joanna Collingwood, Alex Baldwin, Steven Goodwin, Christopher Exley.   

Abstract

The observation of the co-deposition of metals and amyloid-beta(42) (Abeta(42)) in brain tissue in Alzheimer's disease prompted myriad investigations into the role played by metals in the precipitation of this peptide. Copper is bound by monomeric Abeta(12) and upon precipitation of the copper-peptide complex thereby prevents Abeta(42) from adopting a beta-sheet secondary structure. Copper is also bound by beta-sheet conformers of Abeta(42), and herein we have investigated how this interaction affects the conformation of the precipitated peptide. Copper significantly reduced the thioflavin T fluorescence of aged, fibrillar Abeta(42) with, for example, a 20-fold excess of the metal resulting in a ca 90% reduction in thioflavin T fluorescence. Transmission electron microscopy showed that copper significantly reduced the quantities of amyloid fibrils while Congo red staining and polarized light demonstrated a copper-induced abolition of apple-green birefringence. Microscopy under cross-polarized light also revealed the first observation of spherulites of Abeta(42). The size and appearance of these amyloid structures were found to be very similar to spherulites identified in Alzheimer's disease tissue. The combined results of these complementary methods strongly suggested that copper abolished the beta-sheet secondary structure of pre-formed, aged amyloid fibrils of Abeta(42). Copper may protect against the presence of beta-sheets of Abeta(42) in vivo, and its binding by fibrillar Abeta(42) could have implications for Alzheimer's disease therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749401      PMCID: PMC2857508          DOI: 10.3233/JAD-2009-1235

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  Cu(2+) Inhibits the Aggregation of Amyloid beta-Peptide(1-42) in vitro We thank JEOL for the AFM measurement. This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Science, Sports, and Culture, and a Grant from "Research for the Future" Program of the Japan Society for the Promotion of Science to N.S.

Authors:  Jin Zou; Katsushi Kajita; Naoki Sugimoto
Journal:  Angew Chem Int Ed Engl       Date:  2001-06-18       Impact factor: 15.336

Review 2.  Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta_{42} in senile plaque cores in Alzheimer's disease.

Authors:  Christopher Exley
Journal:  J Alzheimers Dis       Date:  2006-11       Impact factor: 4.472

3.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

4.  Histochemical and topo-optical investigations on tissue-isolated and in vitro amyloid fibrils.

Authors:  Thomas R Appel; Susann Richter; Reinhold P Linke; Josef Makovitzky
Journal:  Amyloid       Date:  2005-09       Impact factor: 7.141

5.  Redox cycling of iron by Abeta42.

Authors:  Ayesha Khan; Jon P Dobson; Christopher Exley
Journal:  Free Radic Biol Med       Date:  2005-10-14       Impact factor: 7.376

6.  The formation of spherulites by amyloid fibrils of bovine insulin.

Authors:  Mark R H Krebs; Cait E Macphee; Aline F Miller; Iain E Dunlop; Christopher M Dobson; Athene M Donald
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

7.  Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.

Authors:  Emily House; Joanna Collingwood; Ayesha Khan; Olga Korchazkina; Guy Berthon; Christopher Exley
Journal:  J Alzheimers Dis       Date:  2004-06       Impact factor: 4.472

8.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

9.  Thioflavin T fluorescence assay for beta-lactoglobulin fibrils hindered by DAPH.

Authors:  Ardy Kroes-Nijboer; Yvette S Lubbersen; Paul Venema; Erik van der Linden
Journal:  J Struct Biol       Date:  2008-12-03       Impact factor: 2.867

10.  Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form.

Authors:  Claire J Sarell; Christopher D Syme; Stephen E J Rigby; John H Viles
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

View more
  13 in total

1.  The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.

Authors:  Anuj K Sharma; Stephanie T Pavlova; Jaekwang Kim; Jungsu Kim; Liviu M Mirica
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

2.  Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases.

Authors:  David T Hickman; María Pilar López-Deber; Dorin Mlaki Ndao; Alberto B Silva; Deepak Nand; Maria Pihlgren; Valérie Giriens; Rime Madani; Annie St-Pierre; Hristina Karastaneva; Luitgard Nagel-Steger; Dieter Willbold; Detlev Riesner; Claude Nicolau; Marc Baldus; Andrea Pfeifer; Andreas Muhs
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

3.  High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron.

Authors:  Vijay Antharam; Joanna F Collingwood; John-Paul Bullivant; Mark R Davidson; Saurav Chandra; Albina Mikhaylova; Mary E Finnegan; Christopher Batich; John R Forder; Jon Dobson
Journal:  Neuroimage       Date:  2011-08-16       Impact factor: 6.556

4.  Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions.

Authors:  Giuseppe Caruso; Donatella A Distefano; Paolo Parlascino; Claudia G Fresta; Giuseppe Lazzarino; Susan M Lunte; Vincenzo G Nicoletti
Journal:  Mol Cell Biochem       Date:  2016-11-01       Impact factor: 3.396

5.  Spherulites of amyloid-beta42 in vitro and in Alzheimer's disease.

Authors:  Christopher Exley; Emily House; Joanna F Collingwood; Mark R Davidson; Danielle Cannon; Athene M Donald
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Copper and its complexes in medicine: a biochemical approach.

Authors:  Isidoros Iakovidis; Ioannis Delimaris; Stylianos M Piperakis
Journal:  Mol Biol Int       Date:  2011-06-15

7.  Small bifunctional chelators that do not disaggregate amyloid β fibrils exhibit reduced cellular toxicity.

Authors:  Anuj K Sharma; Jaekwang Kim; John T Prior; Nicholas J Hawco; Nigam P Rath; Jungsu Kim; Liviu M Mirica
Journal:  Inorg Chem       Date:  2014-10-21       Impact factor: 5.165

8.  Copper prevents amyloid-β(1-42) from forming amyloid fibrils under near-physiological conditions in vitro.

Authors:  Matthew Mold; Larissa Ouro-Gnao; Beata M Wieckowski; Christopher Exley
Journal:  Sci Rep       Date:  2013-02-13       Impact factor: 4.379

Review 9.  The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light.

Authors:  Joanna F Collingwood; Mark R Davidson
Journal:  Front Pharmacol       Date:  2014-08-19       Impact factor: 5.810

Review 10.  Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer's Disease.

Authors:  Qian-Qian Ouyang; Shannon Zhao; Si-Dong Li; Cai Song
Journal:  Mar Drugs       Date:  2017-11-07       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.